Trial site
Multiprofile Hospital For Active Treatment "Dr. Tota Venkova" AD
- 20running trials
- 23closed trials
The trials here
What the 43 trials at this site are about, from their registry records.
- Conditions
- COPD6 trials
- Psoriasis5 trials
- Metastatic breast cancer4 trials
- Atopic dermatitis (eczema)3 trials
- Bladder cancer3 trials
- Heart failure3 trials
- Lung cancer3 trials
- Asthma2 trials
- Atrial fibrillation2 trials
- Coronary artery disease2 trials
- Prostate cancer2 trials
- Childhood cancers1 trial
- and 5 more
- Phase
- Phase 336 trials
- Phase 23 trials
- Phase 43 trials
- Phase 2/31 trial
- Status
- Completed23 trials
- Active, not recruiting11 trials
- Recruiting8 trials
- Not yet recruiting1 trial
- Lead sponsor
- Pfizer6 trials
- Chiesi Farmaceutici S.p.A.5 trials
- Sanofi4 trials
- Takeda3 trials
- Alumis Inc2 trials
- and 20 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Efepoetin alfa for treatment of anemia in chronic kidney disease on dialysis
Recruiting
Recruiting
Active, not recruiting
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis
Recruiting
Completed
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure2 recruiting
- Asthma1 recruiting
- Bladder cancer1 recruiting
- Chronic kidney disease1 recruiting
- Chronic rhinosinusitis with nasal polyps1 recruiting
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Completed
Completed
A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis
Active, not recruiting
Completed
Completed
Active, not recruiting
Completed
Completed
A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD
Active, not recruiting
Completed
Completed
Completed
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Active, not recruiting
Completed
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
Completed
Completed
Completed
A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia.
Completed
The efficacy and safety of two doses of CHF6001 DPI as add-on to maintenance COPD triple therapy
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026